Members of the Exelixis management team, left to right: P.J. Haley, MBA, Senior Vice President, Commercial; Laura Dillard, Senior Vice President, Human Resources; Dana Aftab, Ph.D., Executive Vice President (EVP), Business Operations; Peter Lamb, Ph.D., EVP, Scientific Strategy and Chief Scientific Officer; Michael M. Morrissey, Ph.D., President and Chief Executive Officer; Christopher J. Senner, EVP and Chief Financial Officer; Gisela M. Schwab, M.D., President, Product Development and Medical Affairs and Chief Medical Officer; Jeffrey J. Hessekiel, J.D., EVP and General Counsel; Susan Hubbard, EVP, Public Affairs and Investor Relations.

Our leadership team is united by an unwavering commitment to creating value through the development of innovative new therapies to improve the treatment of cancer. Bringing together years of industry experience, our dedicated team shares the same vision to create therapies that make a meaningful difference in the lives of patients.

Michael M. Morrissey, Ph.D.
President and Chief Executive Officer

Gisela M. Schwab, M.D.
President, Product Development and Medical Affairs and Chief Medical Officer

Christopher J. Senner
Executive Vice President and Chief Financial Officer

Dana Aftab, Ph.D.
Executive Vice President, Business Operations

Laura Dillard
Senior Vice President, Human Resources

P.J. Haley, MBA
Senior Vice President, Commercial

Jeffrey J. Hessekiel, J.D.
Executive Vice President and General Counsel

Susan Hubbard
Executive Vice President, Public Affairs and Investor Relations

Peter Lamb, Ph.D.
Executive Vice President, Scientific Strategy and Chief Scientific Officer